Science Explorer Back to mapMap
Discussion
Company · Turku · Finland

Pharmatest (Finland)

pharmatest.comROR OpenAlex
Research works
85
▼ 61% vs 2018-21
Citations
816
9.5 per fractional work
Top-10% rate
4.2%
all institutions 10.0%
Open access
31%
world 40%
International
39%
world 18%
Pharmatest (Finland)

Not ranked overall: Pharmatest (Finland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Pharmatest (Finland) work in?

In all years, 71% of research at Pharmatest (Finland) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (70%), Biochemistry, Genetics and Molecular Biology (20%), Engineering (4%). It does 2.8× the world's share of Health Sciences.

Health Sciences: 61 fractional works · 70.9% of its workMedicine: 60 fractional works · 69.6% of its workOncology: 15 fractional works · 17.6% of its workRadiology, Nuclear Medicine and Imaging: 11 fractional works · 12.6% of its workPulmonary and Respiratory Medicine: 9 fractional works · 10.3% of its workRheumatology: 6 fractional works · 7.3% of its workPharmacology: 4 fractional works · 4.2% of its workOrthopedics and Sports Medicine: 3 fractional works · 3.3% of its workSurgery: 2 fractional works · 2.5% of its workHematology: 2 fractional works · 2.4% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.2% of its workUrology: 1 fractional works · 1.1% of its workPathology and Forensic Medicine: 1 fractional works · 1.0% of its workPhysiology: 1 fractional works · 1.0% of its workPsychiatry and Mental health: 1 fractional works · 0.8% of its workHepatology: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.5% of its workNephrology: 0 fractional works · 0.4% of its workEpidemiology: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.4% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workInfectious Diseases: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workHealth Professions: 0 fractional works · 0.5% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.2% of its workNutrition and Dietetics: 0 fractional works · 0.2% of its workDentistry: 0 fractional works · 0.1% of its workLife Sciences: 20 fractional works · 23.4% of its workBiochemistry, Genetics and Molecular Biology: 17 fractional works · 19.6% of its workMolecular Biology: 8 fractional works · 9.2% of its workCancer Research: 4 fractional works · 4.1% of its workGenetics: 3 fractional works · 3.1% of its workBiotechnology: 2 fractional works · 2.8% of its workCell Biology: 0 fractional works · 0.4% of its workImmunology and Microbiology: 2 fractional works · 2.7% of its workImmunology: 2 fractional works · 2.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.6% of its workFood Science: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmaceutical Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 4 fractional works · 4.4% of its workEngineering: 3 fractional works · 3.8% of its workBiomedical Engineering: 2 fractional works · 2.7% of its workComputational Mechanics: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.5% of its workChemistry: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workChemical Engineering: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 1.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.2% of its workEconomics and Econometrics: 1 fractional works · 1.2% of its workArts and Humanities: 0 fractional works · 0.1% of its workALL ITS WORKPharmatest(Finland)85fractional works, all years
Life Sciences23%Physical Sciences4%Health Sciences71%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine6069.6%
    2. Health Professions00.5%
    3. Veterinary00.4%
    4. Nursing00.2%
    5. Dentistry00.1%
    1. Biochemistry, Genetics and Molecular Biology1719.6%
    2. Immunology and Microbiology22.7%
    3. Agricultural and Biological Sciences00.6%
    4. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Engineering33.8%
    2. Chemistry00.3%
    3. Computer Science00.1%
    4. Environmental Science00.1%
    5. Physics and Astronomy00.1%
    6. Chemical Engineering00.1%
    1. Economics, Econometrics and Finance11.2%
    2. Arts and Humanities00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.69× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 0.94× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 1.34× its world share, 0 worksPharmacology, Toxico…Engineering: 0.05× its world share, 0 worksEngineeringHealth Professions: 0.18× its world share, 0 worksHealth ProfessionsMedicine: 4.04× its world share, 11 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Medicine4.04×11 works
  2. Biochemistry, Genetics and Molecular Biology3.69×3 works
  3. Pharmacology, Toxicology and Pharmaceutics1.34×0 works
  4. Immunology and Microbiology0.94×0 works
  5. Health Professions0.18×0 works
  6. Engineering0.05×0 works

Who are the top researchers at Pharmatest (Finland)?

Ranked on the quality score, Esa J. Alhoniemi, Jussi M. Halleen and Jenni H. Mäki-Jouppila lead among researchers whose main affiliation is Pharmatest (Finland).

  1. 1 Esa J. Alhoniemi Finland · #1,110,370 worldwide 5.3k citations · 87 works
  2. 2 Jussi M. Halleen Finland · #1,196,166 worldwide 5.5k citations · 188 works
  3. 3 Jenni H. Mäki-Jouppila Finland · #1,582,663 worldwide 460 citations · 66 works
  4. 4 Justyna Zdrojewska Finland · #1,925,557 worldwide 428 citations · 27 works
  5. 5 Zhiqi Peng Finland · #2,224,402 worldwide 1.1k citations · 27 works
  6. 6 Jukka P. Vääräniemi Finland · #2,281,253 worldwide 956 citations · 32 works
  7. 7 Katja M. Fagerlund Finland · #2,389,948 worldwide 663 citations · 67 works
  8. 8 Jukka P. Morko Finland · #2,580,370 worldwide 1k citations · 35 works
  9. 9 Mari I. Suominen Finland · #2,595,355 worldwide 659 citations · 110 works
  10. 10 Jukka P. Rissanen Finland · #2,858,881 worldwide 713 citations · 74 works
All ranked researchers at Pharmatest (Finland)

What are the most cited papers from Pharmatest (Finland)?

The most cited paper from Pharmatest (Finland) is "Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib" (Heikki Joensuu, Eva Wardelmann, Harri J. Sihto et al., 2017), with 192 citations. Next come "Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models" (178) and "Serum TRACP 5b Is a Useful Marker for Monitoring Alendronate Treatment: Comparison With Other Markers of Bone Turnover" (167).

Most cited papers
#PaperReleasedCitations
1 Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib Heikki Joensuu, Eva Wardelmann, Harri J. Sihto et al. · JAMA Oncology Open access 24 Mar 2017 192
2 Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models Mari I. Suominen, Katja M. Fagerlund, Jukka P. Rissanen et al. · Clinical Cancer Research Open access 31 Mar 2017 178
3 Serum TRACP 5b Is a Useful Marker for Monitoring Alendronate Treatment: Comparison With Other Markers of Bone Turnover Arja Nenonen, Sulin Cheng, Kaisa K. Ivaska et al. · Journal of Bone and Mineral Research Open access Oct 2005 167
4 Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study Caroline E. Childs, Henna Röytiö, Esa J. Alhoniemi et al. · British Journal Of Nutrition Open access 24 Mar 2014 166
5 Characterization of pulmonary function in Duchenne Muscular Dystrophy Oscar Henry Mayer, Richard S. Finkel, Christian Rummey et al. · Pediatric Pulmonology Open access 9 Mar 2015 156
All 99 most cited papers, with filters and sorting

Which keywords describe research at Pharmatest (Finland)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Treatment, Prostate Cancer, Immunotherapy, Inflammation, Breast Cancer, Targeted Therapy, PET Imaging and Genetic Mutations.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Treatment16▲ 71×3 topics
  2. Prostate Cancer15▲ 114×2 topics
  3. Inflammation12▲ 5.9×19 topics
  4. Immunotherapy12▲ 21×6 topics
  5. Breast Cancer10▲ 41×5 topics
  6. Targeted Therapy8▲ 44×2 topics
  7. PET Imaging8▲ 43×3 topics
  8. Clinical Trials8▲ 15×4 topics
  9. Genetic Mutations8▲ 18×4 topics
  10. Biomarkers8▲ 15×4 topics
  11. Cancer8▲ 6.5×12 topics
  12. Clinical Practice Guidelines8▲ 16×6 topics
  13. Radioimmunotherapy8▲ 227×1 topic
  14. Radiopharmaceuticals8▲ 227×1 topic
  15. Hormone Therapy8▲ 84×3 topics
  16. Androgen Receptor7▲ 93×1 topic
  17. Bisphosphonates7▲ 221×1 topic
  18. Genomic Profiling7▲ 86×1 topic
  19. Osteonecrosis of the Jaw7▲ 221×1 topic
  20. Mesenchymal Stem Cells6▲ 59×2 topics
  21. Regeneration6▲ 39×2 topics
  22. Matrix Metalloproteinases6▲ 42×2 topics
  23. Cartilage6▲ 144×1 topic
  24. Osteoarthritis6▲ 53×1 topic
  25. Tumor Microenvironment5▲ 17×3 topics
  26. Bone Resorption4▲ 179×1 topic
  27. Osteoclast Differentiation4▲ 179×1 topic
  28. Tumor Targeting4▲ 33×2 topics
  29. Cardiovascular Risk4▲ 12×3 topics
  30. Tumor Metastasis3▲ 66×2 topics
  31. Epithelial-Mesenchymal Transition3▲ 44×2 topics
  32. Cancer Stem Cells3▲ 86×1 topic
  33. Colorectal Cancer3▲ 39×2 topics
  34. Drug Resistance3▲ 12×2 topics
  35. Gene Therapy3▲ 14×2 topics
  36. Parathyroid Hormone3▲ 36×2 topics
  37. Stem Cell Niches3▲ 86×1 topic
  38. Cyclooxygenase-2 Inhibitors3▲ 95×1 topic
  39. Prostaglandins3▲ 95×1 topic
  40. Bone Mineral Density3▲ 40×2 topics

Which research topics does Pharmatest (Finland) publish most on?

By volume in 2022-now: Prostate Cancer Treatment and Research, Osteoarthritis Treatment and Mechanisms, Radiopharmaceutical Chemistry and Applications and Inflammatory mediators and NSAID effects.

Prostate Cancer Treatment and Research: 2 fractional worksOsteoarthritis Treatment and Mechanisms: 2 fractional worksRadiopharmaceutical Chem…1Radiopharmaceutical Chemistry and Applications: 1 fractional worksInflammatory mediators a…1Inflammatory mediators and NSAID effects: 1 fractional worksBone health and treatments: 1 fractional worksBone Metabolism and Dise…1Bone Metabolism and Diseases: 1 fractional worksMultiple Myeloma Research and Treatments: 1 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksCancer Research and Treatments: 0 fractional worksPluripotent Stem Cells Research: 0 fractional works
Pulmonary and Respiratory MedicineRheumatologyRadiology, Nuclear Medicine and ImagingPharmacology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 2 works
  2. 2 Osteoarthritis Treatment and Mechanisms Rheumatology 2 works
  3. 3 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Inflammatory mediators and NSAID effects Pharmacology 1 works
  5. 5 Bone health and treatments Oncology 1 works
  6. 6 Bone Metabolism and Diseases Molecular Biology 1 works
  7. 7 Multiple Myeloma Research and Treatments Hematology 1 works
  8. 8 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 Pluripotent Stem Cells Research Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.6%not open69.4%

World: 40% of research is openly available.

with international co-authors39.3%domestic only60.7%

World: 18% is written across borders.

How has Pharmatest (Finland)'s research output changed?

Output in 2022-2025 was 61% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Pharmatest (Finland) as a percentage of every work published that year, 0.000055% in 2024.

still counting0.00020%0.00040%Pharmatest (Finland)0.000015% in 2025200020102020

Fractional works of Pharmatest (Finland) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Turku

All research institutions in Turku

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Pharmatest (Finland). Posts are plain text and can be reported.